文献速递糖尿病性腺与生殖内分泌

TODAY研究中青少年2型糖尿病女孩的月经功能障碍

Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该研究为TODAY研究的二次分析,纳入190名至少月经初潮后1年且未使用激素避孕的2型糖尿病女孩,21%存在月经不规则。月经不规则组较规则组BMI、AST、游离雄激素指数和总睾酮更高,SHBG和雌二醇更低,且差异经BMI调整后仍存在。降糖治疗组在12或24个月时对月经或性激素无影响。

要点

  • 青少年2型糖尿病女孩中21%存在月经不规则(既往6个月内月经≤3次)。
  • 月经不规则与BMI、AST、游离雄激素指数、总睾酮升高及SHBG、雌二醇降低相关,BMI调整后仍存在。
  • 降糖治疗(二甲双胍±罗格列酮或二甲双胍+生活方式)在12或24个月时对月经或性激素无影响。

核心结论

  • 月经功能障碍在 recently diagnosed 2型糖尿病女孩中常见,与性激素、SHBG和AST改变相关,但与胰岛素敏感性或β细胞功能无关,且2年降糖治疗未改善。

研究设计与样本

  • TODAY研究的二次分析,多中心学术环境,纳入未使用激素避孕且至少月经初潮后1年的TODAY女孩,比较月经规则与不规则组的人口学、代谢和激素特征,并评估治疗组(二甲双胍±罗格列酮、二甲双胍+生活方式)对月经和性激素的影响。
  • 共190名有性激素血清测量的合格参与者,平均年龄14岁。

主要发现

  • 190名参与者中21%存在月经不规则(既往6个月内月经≤3次)。
  • 月经不规则组 vs 规则组:BMI更高(P=0.001)、AST更高(P=0.001)、游离雄激素指数更高(P=0.0003)、总睾酮更高(P=0.01)、SHBG更低(P=0.004)、雌二醇更低(P=0.01),BMI调整后差异仍存在。
  • 治疗组在12或24个月时对月经或性激素无影响,性激素与胰岛素敏感性或分泌指标无关联。

关键数值与推荐

  • 月经不规则定义:既往6个月内月经≤3次。
  • 月经不规则组 vs 规则组:BMI(P=0.001)、AST(P=0.001)、游离雄激素指数(P=0.0003)、总睾酮(P=0.01)更高,SHBG(P=0.004)和雌二醇(P=0.01)更低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Little is known about reproductive function in girls with youth-onset type 2 diabetes. OBJECTIVES: To characterize girls with irregular menses and effects of glycemic treatments on menses and sex steroids in the Treatment Options for Type 2 Diabetes in Youth (TODAY) study. DESIGN: Differences in demographic, metabolic, and hormonal characteristics between regular- vs irregular-menses groups were tested; treatment group (metformin with or without rosiglitazone, metformin plus lifestyle) effect on menses and sex steroids over time in the study was assessed. This is a secondary analysis of TODAY data. SETTING: Multicenter study in an academic setting. PATIENTS: TODAY girls not receiving hormonal contraception and those at least 1-year postmenarche were included. Irregular menses was defined as three or fewer periods in the prior 6 months. RESULTS: Of eligible participants with serum measurement of sex steroids (n = 190; mean age, 14 years), 21% had irregular menses. Those with irregular vs regular menses had higher body mass index (BMI) (P = 0.001), aspartate aminotransferase (AST) (P = 0.001), free androgen index (P = 0.0003), and total testosterone (P = 0.01) and lower sex hormone-binding globulin (SHBG) (P = 0.004) and estradiol (P = 0.01). Differences remained after adjustment for BMI. There was no treatment group effect on menses or sex steroids at 12 or 24 months, and no association of sex steroids was seen with measures of insulin sensitivity or secretion. CONCLUSIONS: Menstrual dysfunction is common in girls with recently diagnosed type 2 diabetes and associated with alterations in sex steroids, SHBG, and AST but not with alteration in insulin sensitivity or β-cell function and did not improve with 2 years of antihyperglycemic treatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kelsey MM, Braffett BH, Geffner ME, et al. Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. J Clin Endocrinol Metab. 2018. PMID: 29697830. doi:10.1210/jc.2018-00132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。